Penumbra Price to Book Ratio 2014-2025 | PEN
Historical price to book ratio values for Penumbra (PEN) over the last 10 years. The current price to book ratio for Penumbra as of May 21, 2025 is 8.63.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Penumbra Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-21 | 270.39 | 8.62 | |
| 2025-03-31 | 267.41 | $31.35 | 8.53 |
| 2024-12-31 | 237.48 | $29.90 | 7.94 |
| 2024-09-30 | 194.31 | $28.79 | 6.75 |
| 2024-06-30 | 179.97 | $29.90 | 6.02 |
| 2024-03-31 | 223.18 | $31.05 | 7.19 |
| 2023-12-31 | 251.54 | $30.48 | 8.25 |
| 2023-09-30 | 241.91 | $28.63 | 8.45 |
| 2023-06-30 | 344.06 | $27.77 | 12.39 |
| 2023-03-31 | 278.69 | $26.79 | 10.40 |
| 2022-12-31 | 222.46 | $26.21 | 8.49 |
| 2022-09-30 | 189.60 | $25.65 | 7.39 |
| 2022-06-30 | 124.52 | $25.60 | 4.86 |
| 2022-03-31 | 222.13 | $25.47 | 8.72 |
| 2021-12-31 | 287.32 | $25.39 | 11.32 |
| 2021-09-30 | 266.50 | $18.33 | 14.54 |
| 2021-06-30 | 274.06 | $18.41 | 14.89 |
| 2021-03-31 | 270.58 | $17.83 | 15.18 |
| 2020-12-31 | 175.00 | $17.51 | 9.99 |
| 2020-09-30 | 194.38 | $17.07 | 11.39 |
| 2020-06-30 | 178.82 | $17.29 | 10.34 |
| 2020-03-31 | 161.33 | $13.92 | 11.59 |
| 2019-12-31 | 164.27 | $13.87 | 11.84 |
| 2019-09-30 | 134.49 | $13.38 | 10.06 |
| 2019-06-30 | 160.00 | $13.06 | 12.25 |
| 2019-03-31 | 147.01 | $12.63 | 11.64 |
| 2018-12-31 | 122.20 | $12.27 | 9.96 |
| 2018-09-30 | 149.70 | $11.86 | 12.62 |
| 2018-06-30 | 138.15 | $12.37 | 11.17 |
| 2018-03-31 | 115.65 | $12.11 | 9.55 |
| 2017-12-31 | 94.10 | $11.89 | 7.92 |
| 2017-09-30 | 90.30 | $11.31 | 7.98 |
| 2017-06-30 | 87.75 | $11.04 | 7.95 |
| 2017-03-31 | 83.45 | $11.11 | 7.51 |
| 2016-12-31 | 63.80 | $8.57 | 7.45 |
| 2016-09-30 | 75.99 | $8.02 | 9.47 |
| 2016-06-30 | 59.50 | $7.97 | 7.46 |
| 2016-03-31 | 46.00 | $7.75 | 5.93 |
| 2015-12-31 | 53.81 | $7.78 | 6.92 |
| 2015-09-30 | 40.10 | $7.65 | 5.24 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.471B | $1.195B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $196.080B | 85.88 |
| Thermo Fisher Scientific (TMO) | United States | $150.348B | 18.19 |
| Edwards Lifesciences (EW) | United States | $44.640B | 29.27 |
| Alcon (ALC) | Switzerland | $43.179B | 29.18 |
| IDEXX Laboratories (IDXX) | United States | $40.281B | 46.29 |
| DexCom (DXCM) | United States | $33.286B | 51.45 |
| STERIS (STE) | Ireland | $24.202B | 26.69 |
| IQVIA Holdings (IQV) | United States | $23.751B | 13.30 |
| Mettler-Toledo (MTD) | United States | $23.552B | 28.01 |
| Waters (WAT) | United States | $20.671B | 29.17 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.948B | 0.00 |
| Hologic (HOLX) | United States | $12.216B | 13.27 |
| Sysmex ADR (SSMXY) | Japan | $10.569B | 29.98 |
| Globus Medical (GMED) | United States | $8.153B | 19.12 |
| Masimo (MASI) | United States | $8.100B | 29.88 |
| Glaukos (GKOS) | United States | $5.418B | 0.00 |
| Teleflex (TFX) | United States | $5.390B | 8.90 |
| Integer Holdings (ITGR) | United States | $4.148B | 21.73 |
| TransMedics (TMDX) | United States | $4.103B | 89.20 |
| PROCEPT BioRobotics (PRCT) | United States | $3.134B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.381B | 14.18 |
| Veracyte (VCYT) | United States | $2.162B | 30.34 |
| Nihon Kohden (NHNKY) | Japan | $2.106B | 24.16 |
| Elekta AB (EKTAY) | Sweden | $2.050B | 18.43 |
| Alphatec Holdings (ATEC) | United States | $1.851B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.442B | 0.00 |
| Artivion (AORT) | United States | $1.219B | 114.20 |
| Pulse Biosciences (PLSE) | United States | $1.164B | 0.00 |
| OPKO Health (OPK) | United States | $1.031B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.986B | 5.24 |
| SiBone (SIBN) | United States | $0.815B | 0.00 |
| IRadimed (IRMD) | United States | $0.677B | 34.33 |
| Beta Bionics (BBNX) | United States | $0.675B | 0.00 |
| RxSight (RXST) | United States | $0.651B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.608B | 13.30 |
| Delcath Systems (DCTH) | United States | $0.600B | 0.00 |
| NeuroPace (NPCE) | United States | $0.595B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.587B | 9.14 |
| OrthoPediatrics (KIDS) | United States | $0.531B | 0.00 |
| AxoGen (AXGN) | United States | $0.519B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.501B | 13.32 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.449B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.396B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.389B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.340B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.294B | 0.00 |
| Neuronetics (STIM) | United States | $0.264B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.229B | 13.87 |
| Alpha Tau Medical (DRTS) | Israel | $0.219B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.167B | 0.00 |
| Accuray (ARAY) | United States | $0.167B | 0.00 |
| 908 Devices (MASS) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| CVRx (CVRX) | United States | $0.163B | 0.00 |
| Inogen (INGN) | United States | $0.160B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.139B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.128B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.112B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.100B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.092B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 47.10 |
| InspireMD (NSPR) | Israel | $0.068B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.83 |
| Hyperfine (HYPR) | United States | $0.046B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.042B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.03 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |